Usefulness of circulating E-selectin to early detection of the atherosclerotic process in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Imagem de Miniatura
Arquivos
art_ALMEIDA-PITITTO_Usefulness_of_circulating_Eselectin_to_early_detection_of_2016.PDF (921.27 KB)
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2016
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
ALMEIDA-PITITTO, Bianca de
RIBEIRO-FILHO, Fernando Flexa
FERREIRA, Sandra R. G.
Citação
DIABETOLOGY & METABOLIC SYNDROME, v.8, article ID 19, 7p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: This cross-sectional analysis evaluated whether determination of E-selectin concentrations could identify deterioration of cardiometabolic risk profile or subclinical atherosclerosis in individuals at low-to-moderate risk included in The Brazilian Longitudinal Study of Adult Health-ELSA-Brasil. Methods: A sample of 984 individuals from ELSA-Brasil (35-54 years) without cardiovascular disease or diabetes was stratified according to E-selectin tertiles. Traditional risk factors, inflammatory markers and categories of coronary artery calcium (CAC) scores were evaluated across the tertiles by ANOVA or Chi-squared test. In linear regression models, associations of E-selectin levels with insulin resistance index, adjusted for age, sex and adiposity were tested. Results: The mean age of the participants was 45.8 (SD 4.9) years and 55 % were women. Mean values of age, anthropometric data, biochemical variables and inflammatory status increased across E-selectin tertiles. Also, a gradual deterioration of the cardiometabolic profile was reflected by increments in frequencies (95 % CI) of BMI >= 25 kg/m(2) [53.7 % (48.5-58.8), 61.0 % (56.1-66.5) and 64.2 % (59.0-69.4), p = 0.019], hypertension [18.0 % (14.1-22.8), 19.8 % (15.4-24.6) and 24.8 % (20.4-29.9), p = 0.048], pre-diabetes [62.5 % (57.4-68.3), 63.1 % (58.4-69.6) and 73.8 % (68.8-78.3), p = 0.003] and hypertriglyceridemia [22.4 % (17.9-27.2), 27.3 % (22.5-32.8) and 33.4 % (28.3-38.5), p = 0.013]. Insulinemia and HOMA-IR were independently associated with E-selectin concentration. A greater proportion of individuals with CAC scores different from zero was found in the third tertile when compared with the first and second tertiles (16.1 versus 11 %, p = 0.04, respectively). Conclusions: Direct associations of E-selectin with traditional risk factors slightly above their normal ranges, components of the metabolic syndrome, insulin resistance and presence of CAC suggest that this biomarker may indicate an initial atherogenic process.
Palavras-chave
E-selectin, Insulin resistance, Atherosclerosis, Endothelial dysfunction, Cardiovascular risk factors
URI
https://observatorio.fm.usp.br/handle/OPI/13882
Referências
  1. American Diabetes Association, 2010, DIABETES CARE S1, V33, pS62, DOI [DOI 10.2337/DC10-S062, 10.2337/dc10-S062]
  2. Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21
  3. Almeida-Pititto B, 2015, DIABETES RES CLIN PR, V109, P110, DOI 10.1016/j.diabres.2015.04.021
  4. Bonora E, 2002, DIABETES CARE, V25, P1135, DOI 10.2337/diacare.25.7.1135
  5. Fedeli LG, 2013, REV SAUDE PUBL, V47, P63, DOI 10.1590/S0034-8910.2013047003807
  6. Ridker PM, 2000, CIRCULATION, V101, P2149
  7. Danesh J, 2000, BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199
  8. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  9. Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030
  10. Levi F, 2002, HEART, V88, P119, DOI 10.1136/heart.88.2.119
  11. Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978
  12. Rahman A, 1998, AM J PHYSIOL-LUNG C, V275, pL533
  13. GEARING AJH, 1992, ANN NY ACAD SCI, V667, P324, DOI 10.1111/j.1749-6632.1992.tb51633.x
  14. Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060
  15. AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827
  16. Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
  17. Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
  18. Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807
  19. Curioni C, 2009, REV PANAM SALUD PUBL, V25, P9, DOI 10.1590/S1020-49892009000100002
  20. Ridker PM, 2001, CIRCULATION, V103, P491
  21. Elenkov IJ, 2000, ANN NY ACAD SCI, V917, P94
  22. [Anonymous], 2013, REV SAUDE PUBL S2, DOI 10.1590/S0034-8910.2013047003780
  23. Adamska A, 2014, ENDOCRINE, V45, P422, DOI 10.1007/s12020-013-0025-9
  24. ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
  25. Rumberger JA, 1999, MAYO CLIN PROC, V74, P243
  26. Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
  27. Ridker PM, 2000, CIRCULATION, V101, P1767
  28. Christopher JL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMRA1201534
  29. Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278
  30. Hwang SJ, 1997, CIRCULATION, V96, P4219
  31. Jude EB, 2002, EUR J INTERN MED, V13, P185, DOI 10.1016/S0953-6205(02)00014-6
  32. LEFER AM, 1993, P NATL ACAD SCI USA, V90, P1018, DOI 10.1073/pnas.90.3.1018
  33. MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
  34. Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03